209 related articles for article (PubMed ID: 19659771)
1. Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin.
Hayworth JL; Kasper KJ; Leon-Ponte M; Herfst CA; Yue D; Brintnell WC; Mazzuca DM; Heinrichs DE; Cairns E; Madrenas J; Hoskin DW; McCormick JK; Haeryfar SM
Clin Exp Immunol; 2009 Jul; 157(1):60-70. PubMed ID: 19659771
[TBL] [Abstract][Full Text] [Related]
2. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
[TBL] [Abstract][Full Text] [Related]
3. Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B.
Hamel ME; Eynon EE; Savelkoul HF; van Oudenaren A; Kruisbeek AM
Int Immunol; 1995 Jul; 7(7):1065-77. PubMed ID: 8527404
[TBL] [Abstract][Full Text] [Related]
4. Invariant Natural Killer T Cells Are Pathogenic in the HLA-DR4-Transgenic Humanized Mouse Model of Toxic Shock Syndrome and Can Be Targeted to Reduce Morbidity.
Szabo PA; Rudak PT; Choi J; Xu SX; Schaub R; Singh B; McCormick JK; Haeryfar SMM
J Infect Dis; 2017 Mar; 215(5):824-829. PubMed ID: 28035011
[TBL] [Abstract][Full Text] [Related]
5. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes.
D'Orazio JA; Stein-Streilein J
Clin Exp Immunol; 1996 May; 104(2):366-73. PubMed ID: 8625534
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcal enterotoxin B-induced activation and concomitant resistance to cell death in CD28-deficient HLA-DQ8 transgenic mice.
Rajagopalan G; Smart MK; Marietta EV; David CS
Int Immunol; 2002 Jul; 14(7):801-12. PubMed ID: 12096040
[TBL] [Abstract][Full Text] [Related]
7. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
8. Swift Intrahepatic Accumulation of Granulocytic Myeloid-Derived Suppressor Cells in a Humanized Mouse Model of Toxic Shock Syndrome.
Szabo PA; Goswami A; Memarnejadian A; Mallett CL; Foster PJ; McCormick JK; Haeryfar SM
J Infect Dis; 2016 Jun; 213(12):1990-5. PubMed ID: 26908735
[TBL] [Abstract][Full Text] [Related]
9. Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.
Karau MJ; Tilahun ME; Krogman A; Osborne BA; Goldsby RA; David CS; Mandrekar JN; Patel R; Rajagopalan G
Virulence; 2017 Oct; 8(7):1148-1159. PubMed ID: 27925510
[TBL] [Abstract][Full Text] [Related]
10. A role for the Tec family kinase ITK in regulating SEB-induced interleukin-2 production in vivo via c-jun phosphorylation.
Ragin MJ; Hu J; Henderson AJ; August A
BMC Immunol; 2005 Jul; 6():19. PubMed ID: 16042784
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody.
Pang LT; Kum WW; Chow AW
Infect Immun; 2000 Jun; 68(6):3261-8. PubMed ID: 10816471
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
Lussow AR; MacDonald HR
Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
[TBL] [Abstract][Full Text] [Related]
13. Unique cytokine production profile of anergic human T cells in SCID-hu mice after staphylococcal enterotoxin B administration.
Schols D; Jones D; Roncarolo MG
J Immunol; 1995 Apr; 154(7):3204-12. PubMed ID: 7534791
[TBL] [Abstract][Full Text] [Related]
14. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
Ijichi S; Yamano Y; Osame M; Hall WW
Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
[TBL] [Abstract][Full Text] [Related]
15. Synovial cells are potent antigen-presenting cells for superantigen, staphylococcal enterotoxin B (SEB).
Origuchi T; Eguchi K; Kawabe Y; Mizokami A; Ida H; Nagataki S
Clin Exp Immunol; 1995 Mar; 99(3):345-51. PubMed ID: 7882555
[TBL] [Abstract][Full Text] [Related]
16. Superantigen enhancement of specific immunity: antibody production and signaling pathways.
Torres BA; Perrin GQ; Mujtaba MG; Subramaniam PS; Anderson AK; Johnson HM
J Immunol; 2002 Sep; 169(6):2907-14. PubMed ID: 12218104
[TBL] [Abstract][Full Text] [Related]
17. Accessory cell function of a human colonic epithelial cell line HT-29 for bacterial superantigens.
Liu ZX; Sugawara S; Hiwatashi N; Noguchi M; Rikiishi H; Kumagai K; Toyota T
Clin Exp Immunol; 1997 Jun; 108(3):384-91. PubMed ID: 9182880
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonists.
Rajagopalan G; Sen MM; David CS
Infect Immun; 2004 Nov; 72(11):6733-7. PubMed ID: 15501813
[TBL] [Abstract][Full Text] [Related]
19. Cell adhesion molecules are co-receptors for staphylococcal enterotoxin B-induced T-cell activation and cytokine production.
Krakauer T
Immunol Lett; 1994 Feb; 39(2):121-5. PubMed ID: 8013959
[TBL] [Abstract][Full Text] [Related]
20. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
Miethke T; Wahl C; Heeg K; Wagner H
J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
